ARTICLE | Company News
Management tracks
April 6, 2016 12:10 AM UTC
Immunotherapy company ImmunoGen Inc. (NASDAQ:IMGN) said President and CEO Daniel Junius will retire, effective when a successor joins the company. Junius will remain on ImmunoGen's board.
Daiichi Sankyo Co. Ltd. (Tokyo:4568) hired Antoine Yver as global head of oncology R&D. Yver was SVP and head of oncology in global medicines development at AstraZeneca plc (LSE:AZN; NYSE:AZN). ...